Successful Fidaxomicin Hospital Discharges of Adult Patients With Clostridioides difficile Infections Post–2021 Guidelines: Are Economic Barriers Finally Coming Down?-Reference-Cited by-同舟云学术

Successful Fidaxomicin Hospital Discharges of Adult Patients With Clostridioides difficile Infections Post–2021 Guidelines: Are Economic Barriers Finally Coming Down?

Published:2021-12-31 Issue: Volume: Page:
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Fang Noah¹,Ha David²³⁴,Dong Kimberly¹,Leung Thomas¹,Lee Sydney¹,Holubar Marisa³⁴^ORCID,Meng Lina²³⁴^ORCID

Affiliation:

1. Department of Pharmacy, Stanford Health Care, Stanford, California, USA

2. Department of Quality, Stanford Health Care, Stanford, California, USA

3. Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA

4. Stanford Antimicrobial Safety and Sustainability Program, Stanford Health Care, Stanford, California, USA

Abstract

Abstract We reviewed Clostridioides difficile–positive patients discharged on fidaxomicin after local adoption of 2021 C. difficile infection (CDI) guidelines. From 14 June to 3 October 2021, 80% (12/15) had copayments of $0–$35 and 27% (4/15) required prior authorization. The 30-day CDI recurrence was 7%.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciab1061/42403940/ciab1061.pdf

Reference12 articles.

1. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults.;Johnson;Clin Infect Dis,2021

2. Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report—part I.;Hay;Value Health,2010

3. Medicare prescription plans limit access to recommended drugs for Clostridioides difficile infection.;Buehrle;Clin Infect Dis,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature;Current Treatment Options in Infectious Diseases;2021-06-29

2. Safety and Reverence: How Roman Catholic Liturgy Can Respond to the COVID-19 Pandemic;Journal of Religion and Health;2021-05-24

3. Development and validation of a nomogram using on admission routine laboratory parameters to predict in‐hospital survival of patients with COVID‐19;Journal of Medical Virology;2020-12-23